Clinical Trial Update: The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery [Phase 3]

View source ↗

Summary

This update reports that the Phase 3 clinical study evaluating Herombopag for treating thrombocytopenia in chronic liver disease patients undergoing elective in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery | Phase 3 | Status: RECRUITING